The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma

L Kou, X Xie, X Chen, B Li, J Li, Y Li - Cancer Immunology …, 2023 - Springer
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in humans,
which is prone to recurrence and metastasis and has a poor prognosis. The occurrence and …
被引用次数：1 相关文章

The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma

L Kou, X Xie, X Chen, B Li, J Li… - Cancer immunology … - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in humans,
which is prone to recurrence and metastasis and has a poor prognosis. The occurrence and …
[HTML] nih.gov

[HTML][HTML] The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma

L Kou, X Xie, X Chen, B Li, J Li, Y Li - Cancer Immunology …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in humans,
which is prone to recurrence and metastasis and has a poor prognosis. The occurrence and …

The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma.

L Kou, X Xie, X Chen, B Li, J Li, Y Li - Cancer Immunology …, 2023 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in humans,
which is prone to recurrence and metastasis and has a poor prognosis. The occurrence and …

The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma.

L Kou, X Xie, X Chen, B Li, J Li, Y Li - Cancer Immunology …, 2023 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in humans,
which is prone to recurrence and metastasis and has a poor prognosis. The occurrence and …